Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study

Ansari E., Pavicic-Astalos J., Ayan F., King A.J., Kinsella M., Ng E., Nita A., The VISIONARY Group

2021
Advances in Therapy

View publication

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

Ansari, E., Maidstone and Tunbridge Wells NHS Trust, University of Kent at Canterbury, Kent, United Kingdom; Pavicic-Astalos, J., Institute of Eye Surgery, UPMC Whitfield, Waterford, Ireland; Ayan, F., Santen UK Ltd, St Albans, United Kingdom; King, A.J., Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Kinsella, M., Buckinghamshire Healthcare NHS Trust, Stoke Mandeville Hospital, Aylesbury, Buckinghamshire, United Kingdom; Ng, E., Institute of Eye Surgery, UPMC Whitfield, Waterford, Ireland; Nita, A., Royal Victoria Infirmary, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; The VISIONARY Group

Related Publications

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.

Valproic Acid Application to Modify Post Surgical Fibrosis in a Model of Minimally Invasive Bleb Surgery

Lo P.F.; Gunawan M.; Yap Z.L.; Leong C.; Kwek F.; Varadarajan J.; Wang X.; Kageyama M.; Wong T.T.

The rate of failure of trabeculectomy and tube shunt surgery in eyes with uveitic glaucoma and ocular hypertension: The purpose of this study is to look at the outcomes of trabeculectomy and tube shunt surgery in a large cohort of patients with uveitis

Groth S.L.; Newcomb C.W.; Yang W.; Payal A.; Begum H.; Khachatryan N.; Kaçmaz R.O.; Dreger K.A.; Rosenbaum J.T.; Nida Sen H.; Suhler E.B.; Thorne J.E.; Bhatt N.P.; Foster C.S.; Jabs D.A.; Levy-Clarke G.A.; Buchanich J.M.; Ying G.S.; Kempen J.H.; Gangaputra S.;

View all Glaucoma publications